{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:09:51Z","timestamp":1768482591633,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05023-6","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T03:32:51Z","timestamp":1748403171000},"page":"5903-5914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrence risk prediction for non-muscle-invasive bladder urothelial carcinoma using diffusion and clinicopathology features"],"prefix":"10.1007","volume":"50","author":[{"given":"Xiaoxian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuedi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuqing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"5023_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209\u2013249. doi: https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"5023_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H et al (2024) Cancer incidence and mortality in China, 2022. J Natl Cancer Cent 4:47\u201353. doi: https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","journal-title":"J Natl Cancer Cent"},{"key":"5023_CR3","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L (2024) Advances in diagnosis and treatment of bladder cancer. BMJ 384:e076743. doi: https:\/\/doi.org\/10.1136\/bmj-2023-076743.","journal-title":"BMJ"},{"key":"5023_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/JU.0000000000003846","volume":"211","author":"JM Holzbeierlein","year":"2024","unstructured":"Holzbeierlein JM, Bixler BR, Buckley DI, et al (2024) Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA\/SUO Guideline: 2024 Amendment. J Urol 211:533\u2013538. doi: https:\/\/doi.org\/10.1097\/JU.0000000000003846.","journal-title":"J Urol"},{"key":"5023_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","volume":"19","author":"JY Teoh","year":"2022","unstructured":"Teoh JY, Kamat AM, Black PC, Grivas P, Shariat SF, Babjuk M (2022) Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective. Nat Rev Urol 19:280\u2013294. doi: https:\/\/doi.org\/10.1038\/s41585-022-00578-1.","journal-title":"Nat Rev Urol"},{"key":"5023_CR6","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/iju.15586","volume":"31","author":"G Palermo","year":"2024","unstructured":"Palermo G, Bizzarri FP, Scarciglia E et al (2024) The mental and emotional status after radical cystectomy and different urinary diversion orthotopic bladder substitution versus external urinary diversion after radical cystectomy: A propensity score-matched study. Int J Urol 31:1423\u20131428. doi: https:\/\/doi.org\/10.1111\/iju.15586.","journal-title":"Int J Urol"},{"key":"5023_CR7","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/cancers16071270","volume":"16","author":"F Gavi","year":"2024","unstructured":"Gavi F, Foschi N, Fettucciari D et al (2024) Assessing Trifecta and Pentafecta Success Rates between Robot-Assisted vs. Open Radical Cystectomy: A Propensity Score-Matched Analysis. Cancers (Basel) 16:1270. doi: https:\/\/doi.org\/10.3390\/cancers16071270.","journal-title":"Cancers (Basel)"},{"key":"5023_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.urolonc.2022.06.008","volume":"40","author":"W Krajewski","year":"2022","unstructured":"Krajewski W, Aumatell J, Subiela JD et al (2022) Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer. Urol Oncol 40:491.e11-491.e19. doi: 10.1016\/j.urolonc.2022.06.008.","journal-title":"Urol Oncol"},{"key":"5023_CR9","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3390\/cancers16091684","volume":"16","author":"A \u015alusarczyk","year":"2024","unstructured":"\u015alusarczyk A, Garbas K, Pustu\u0142a P, Zapa\u0142a \u0141, Radziszewski P (2024) Assessing the Predictive Accuracy of EORTC, CUETO and EAU Risk Stratification Models for High-Grade Recurrence and Progression after Bacillus Calmette-Gu\u00e9rin Therapy in Non-Muscle-Invasive Bladder Cancer. Cancers (Basel) 16:1684. doi: https:\/\/doi.org\/10.3390\/cancers16091684.","journal-title":"Cancers (Basel)"},{"key":"5023_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.euo.2021.05.006","volume":"5","author":"M Jobczyk","year":"2022","unstructured":"Jobczyk M, Stawiski K, Kaszkowiak M et al (2022) Deep Learning-based Recalibration of the CUETO and EORTC Prediction Tools for Recurrence and Progression of Non-muscle-invasive Bladder Cancer. Eur Urol Oncol 5:109\u2013112. doi: https:\/\/doi.org\/10.1016\/j.euo.2021.05.006.","journal-title":"Eur Urol Oncol"},{"key":"5023_CR11","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1002\/cam4.3007","volume":"9","author":"M Jobczyk","year":"2020","unstructured":"Jobczyk M, Stawiski K, Fendler W, R\u00f3\u017ca\u0144ski W (2020) Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non-muscle-invasive bladder cancer (NMIBC): A cohort analysis. Cancer Med 9:4014\u20134025. doi: https:\/\/doi.org\/10.1002\/cam4.3007.","journal-title":"Cancer Med"},{"key":"5023_CR12","doi-asserted-by":"publisher","unstructured":"Bizzarri FP, Nelson AW, Colquhoun AJ, Lobo N (2025) Utility of Fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography in Detecting Lymph Node Involvement in Comparison to Conventional Imaging in Patients with Bladder Cancer with Variant Histology. Eur Urol Oncol. 2025 Apr 17:S2588-9311(25)00097\u2013\u20095. https:\/\/doi.org\/10.1016\/j.euo.2025.03.019.","DOI":"10.1016\/j.euo.2025.03.019"},{"key":"5023_CR13","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.acra.2018.10.016","volume":"26","author":"H Li","year":"2019","unstructured":"Li H, Liu L, Ding L, Zhang Z, Zhang M (2019) Quantitative Assessment of Bladder Cancer Reflects Grade and Recurrence: Comparing of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging. Acad Radiol 26:1148\u20131153. doi: https:\/\/doi.org\/10.1016\/j.acra.2018.10.016.","journal-title":"Acad Radiol"},{"key":"5023_CR14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Narumi Y, Altun E et al (2018) Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 74:294\u2013306. doi: https:\/\/doi.org\/10.1016\/j.eururo.2018.04.029.","journal-title":"Eur Urol"},{"key":"5023_CR15","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1007\/s00330-023-10387-8","volume":"34","author":"X Xu","year":"2024","unstructured":"Xu X, Huang Y et al (2024) Multiparametric MRI-based VI-RADS: can it predict 1- to 5-year recurrence of bladder cancer? Eur Radiol 34:3034\u20133045. doi: https:\/\/doi.org\/10.1007\/s00330-023-10387-8.","journal-title":"Eur Radiol"},{"key":"5023_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13244-024-01662-3","volume":"15","author":"G Yang","year":"2024","unstructured":"Yang G, Bai J, Hao M, Zhang L, Fan Z, Wang X et al (2024) Enhancing recurrence risk prediction for bladder cancer using multi-sequence MRI radiomics. Insights Imaging 15:88. doi: https:\/\/doi.org\/10.1186\/s13244-024-01662-3.","journal-title":"Insights Imaging"},{"key":"5023_CR17","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/jmri.26749","volume":"50","author":"X Xu","year":"2019","unstructured":"Xu X, Wang H, Du P et al (2019) A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors. J Magn Reson Imaging 50:1893\u20131904. doi: https:\/\/doi.org\/10.1002\/jmri.26749.","journal-title":"J Magn Reson Imaging"},{"key":"5023_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.euo.2018.08.018","volume":"2","author":"AB Weiner","year":"2019","unstructured":"Weiner AB, Desai AS, Meeks JJ et al (2019) Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study. Eur Urol Oncol 2:304\u2013310. doi: https:\/\/doi.org\/10.1016\/j.euo.2018.08.018.","journal-title":"Eur Urol Oncol"},{"key":"5023_CR19","doi-asserted-by":"publisher","first-page":"8417","DOI":"10.1007\/s00330-023-09925-1","volume":"33","author":"H Ahn","year":"2023","unstructured":"Ahn H, Kim TM, Hwang SI et al (2023) Tumor contact length with bladder wall provides effective risk stratification for lesions with a VIRADS score of 2\u20133. Eur Radiol 33:8417\u20138425. doi: https:\/\/doi.org\/10.1007\/s00330-023-09925-1.","journal-title":"Eur Radiol"},{"key":"5023_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2214\/AJR.16.16283","volume":"207","author":"HJ Wang","year":"2016","unstructured":"Wang HJ, Pui MH, Guan J et al (2016) Comparison of Early Submucosal Enhancement and Tumor Stalk in Staging Bladder Urothelial Carcinoma. AJR Am J Roentgenol 207:797\u2013803. doi: https:\/\/doi.org\/10.2214\/AJR.16.16283.","journal-title":"AJR Am J Roentgenol"},{"key":"5023_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cac2.12067","volume":"40","author":"J Wu","year":"2020","unstructured":"Wu J, Zhang H, Li L et al (2020) A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis. Cancer Commun (Lond) 40:301\u2013312. doi: https:\/\/doi.org\/10.1002\/cac2.12067.","journal-title":"Cancer Commun (Lond)"},{"key":"5023_CR22","doi-asserted-by":"publisher","first-page":"e248-e254","DOI":"10.1016\/j.clgc.2021.03.001","volume":"19","author":"KM Abd Elwahab","year":"2021","unstructured":"Abd Elwahab KM, Desky EAE, Eldery MS, Mohammad FF, Seleem MM, El-Babouly IM et al (2021) Apparent Diffusion Coefficient Value can Predict Poor Bacillus Calmette-Gu\u00e9rin Responders in T1HG\/NMIBC: Prospective Cohort Study. Clin Genitourin Cancer 19:e248-e254. doi: https:\/\/doi.org\/10.1016\/j.clgc.2021.03.001.","journal-title":"Clin Genitourin Cancer"},{"key":"5023_CR23","doi-asserted-by":"publisher","first-page":"10462","DOI":"10.1002\/cam4.5782","volume":"12","author":"W Zhang","year":"2023","unstructured":"Zhang W, Zhang Z, Xiao W et al (2023) Multiple directional DWI combined with T2WI in predicting muscle layer and Ki-67 correlation in bladder cancer in 3.0-T MRI. Cancer Med 12:10462\u201310472. doi: https:\/\/doi.org\/10.1002\/cam4.5782.","journal-title":"Cancer Med"},{"key":"5023_CR24","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.acra.2024.09.043","volume":"32","author":"JL Li","year":"2025","unstructured":"Li JL, Xu Y, Xiang YS et al (2025) Comparative Analysis of Amide Proton Transfer and Diffusion Weighted Imaging for Assessing Ki-67, p53 and PD-L1 Expression in Bladder Cancer. Acad Radiol 32:834\u2013843. doi: https:\/\/doi.org\/10.1016\/j.acra.2024.09.043.","journal-title":"Acad Radiol"},{"key":"5023_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/bioengineering10070745","volume":"10","author":"X Meng","year":"2023","unstructured":"Meng X, Li S, He K et al (2023) Evaluation of Whole-Tumor Texture Analysis Based on MRI Diffusion Kurtosis and Biparametric VI-RADS Model for Staging and Grading Bladder Cancer. Bioengineering (Basel) 10:745. doi: https:\/\/doi.org\/10.3390\/bioengineering10070745.","journal-title":"Bioengineering (Basel)"},{"key":"5023_CR26","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.4081\/ejh.2020.3098","volume":"64","author":"S Ziaran","year":"2020","unstructured":"Ziaran S, Harsanyi S, Bevizova K et al (2020) Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence. Eur J Histochem 64:3098. doi: https:\/\/doi.org\/10.4081\/ejh.2020.3098.","journal-title":"Eur J Histochem"},{"key":"5023_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00345-024-05148-1","volume":"42","author":"J Ye","year":"2024","unstructured":"Ye J, Tang C, Wu R et al (2024) Preoperative blood-based nutritional biomarkers as significant prognostic factors after intravesical BCG therapy in patients with non-muscle-invasive bladder cancer. World J Urol 42:428. doi: https:\/\/doi.org\/10.1007\/s00345-024-05148-1.","journal-title":"World J Urol"},{"key":"5023_CR28","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s12013-024-01386-7","volume":"82","author":"X Chen","year":"2024","unstructured":"Chen X, Zhou H, Lv J et al (2024) The Importance of Hypoxia-Related to Hemoglobin Concentration in Breast Cancer. Cell Biochem Biophys 82:1893\u20131906. doi: https:\/\/doi.org\/10.1007\/s12013-024-01386-7.","journal-title":"Cell Biochem Biophys"},{"key":"5023_CR29","doi-asserted-by":"publisher","first-page":"7844","DOI":"10.1021\/acs.jafc.9b03027","volume":"67","author":"Y Xia","year":"2019","unstructured":"Xia Y, Kang TW, Jung YD, Zhang C, Lian S et al (2019) Sulforaphane Inhibits Nonmuscle Invasive Bladder Cancer Cells Proliferation through Suppression of HIF-1\u03b1-Mediated Glycolysis in Hypoxia. J Agric Food Chem 67:7844\u20137854. doi: https:\/\/doi.org\/10.1021\/acs.jafc.9b03027.","journal-title":"J Agric Food Chem"},{"key":"5023_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12894-022-01000-z","volume":"22","author":"A Yamamoto","year":"2022","unstructured":"Yamamoto A, Kawashima A, Uemura T et al (2022) Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study. BMC Urol 22:59. doi: https:\/\/doi.org\/10.1186\/s12894-022-01000-z.","journal-title":"BMC Urol"},{"key":"5023_CR31","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.3390\/biomedicines10112925","volume":"10","author":"EY Huang","year":"2022","unstructured":"Huang EY, Chen YK, Ou CP et al (2022) Oncogenic Roles of Polycomb Repressive Complex 2 in Bladder Cancer and Upper Tract Urothelial Carcinoma. Biomedicines 10:2925. doi: https:\/\/doi.org\/10.3390\/biomedicines10112925.","journal-title":"Biomedicines"},{"key":"5023_CR32","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/iju.14372","volume":"27","author":"R Taoka","year":"2020","unstructured":"Taoka R, Matsuoka Y, Kohashiguchi K et al (2020) Impact of second transurethral resection on recurrence in patients with high-grade Ta bladder cancer. Int J Urol 27:1130\u20131135. doi: https:\/\/doi.org\/10.1111\/iju.14372.","journal-title":"Int J Urol"},{"key":"5023_CR33","doi-asserted-by":"publisher","first-page":"e62-e70","DOI":"10.1016\/j.clgc.2019.10.005","volume":"18","author":"Y Waseda","year":"2020","unstructured":"Waseda Y, Kobayashi S, Kanda E et al (2020) Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model. Clin Genitourin Cancer 18:e62-e70. doi: https:\/\/doi.org\/10.1016\/j.clgc.2019.10.005.","journal-title":"Clin Genitourin Cancer"},{"key":"5023_CR34","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1097\/JS9.0000000000001675","volume":"110","author":"L Liu","year":"2024","unstructured":"Liu L, Li K, Wang SG et al (2024) The prognostic impact of tumor location in non-muscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registries. Int J Surg 110:5641\u20135651. doi: https:\/\/doi.org\/10.1097\/JS9.0000000000001675.","journal-title":"Int J Surg"},{"key":"5023_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.euo.2022.07.006","volume":"6","author":"Y Arita","year":"2022","unstructured":"Arita Y, Yoshida S, Shigeta K et al (2022) Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology. Eur Urol Oncol 6:99\u2013102. doi: https:\/\/doi.org\/10.1016\/j.euo.2022.07.006.","journal-title":"Eur Urol Oncol"},{"key":"5023_CR36","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1007\/s00330-019-06119-6","volume":"29","author":"S Yajima","year":"2019","unstructured":"Yajima S, Yoshida S, Takahara T et al (2019) Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression. Eur Radiol 29:3881\u20133888. doi: https:\/\/doi.org\/10.1007\/s00330-019-06119-6.","journal-title":"Eur Radiol"},{"key":"5023_CR37","doi-asserted-by":"publisher","first-page":"e69625","DOI":"10.7759\/cureus.69625","volume":"16","author":"S Hata","year":"2024","unstructured":"Hata S, Fujinami H, Shinohara M et al (2024) Differences in Clinical Outcomes and Survival Among Primary, Secondary, and Concomitant Carcinoma In Situ of the Bladder. Cureus 16: e69625. doi: https:\/\/doi.org\/10.7759\/cureus.69625.","journal-title":"Cureus"},{"key":"5023_CR38","doi-asserted-by":"publisher","first-page":"71.e1","DOI":"10.1016\/j.urolonc.2023.12.005","volume":"42","author":"Z Lone","year":"2023","unstructured":"Lone Z, Benidir T, Wood A et al (2023) Oncologic outcomes of intravesical therapy in the management of nonmuscle invasive bladder cancer with variant histology. Urol Oncol 42:71.e1-71.e7. https:\/\/doi.org\/10.1016\/j.urolonc.2023.12.005","journal-title":"Urol Oncol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05023-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05023-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05023-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:04:08Z","timestamp":1762880648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05023-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5023"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05023-6","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"20 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}